These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 7781591)

  • 1. Insulin action and the insulin signaling network.
    Cheatham B; Kahn CR
    Endocr Rev; 1995 Apr; 16(2):117-42. PubMed ID: 7781591
    [No Abstract]   [Full Text] [Related]  

  • 2. Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway.
    Zierath JR; Livingston JN; Thörne A; Bolinder J; Reynisdottir S; Lönnqvist F; Arner P
    Diabetologia; 1998 Nov; 41(11):1343-54. PubMed ID: 9833943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of PI 3-kinase and SH-PTP2 in insulin action.
    Kasuga M
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S87-9. PubMed ID: 8894489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
    Valverde AM; Lorenzo M; Pons S; White MF; Benito M
    Mol Endocrinol; 1998 May; 12(5):688-97. PubMed ID: 9605931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action.
    White MF
    Recent Prog Horm Res; 1998; 53():119-38. PubMed ID: 9769706
    [No Abstract]   [Full Text] [Related]  

  • 6. The HIV-1 protease inhibitor indinavir impairs insulin signalling in HepG2 hepatoma cells.
    Schütt M; Meier M; Meyer M; Klein J; Aries SP; Klein HH
    Diabetologia; 2000 Sep; 43(9):1145-8. PubMed ID: 11043860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspective: The insulin signaling system--a common link in the pathogenesis of type 2 diabetes.
    Withers DJ; White M
    Endocrinology; 2000 Jun; 141(6):1917-21. PubMed ID: 10830270
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin signal transduction: possible mechanisms for insulin resistance.
    Kellerer M; Lammers R; Häring HU
    Exp Clin Endocrinol Diabetes; 1999; 107(2):97-106. PubMed ID: 10320048
    [No Abstract]   [Full Text] [Related]  

  • 9. Diverse signaling pathways in the cellular actions of insulin.
    Saltiel AR
    Am J Physiol; 1996 Mar; 270(3 Pt 1):E375-85. PubMed ID: 8638681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a prenylation-deficient Rab4 interferes with propagation of insulin signaling through insulin receptor substrate-1.
    Knight JB; Cao KT; Gibson GV; Olson AL
    Endocrinology; 2000 Jan; 141(1):208-18. PubMed ID: 10614641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).
    Band CJ; Posner BI; Dumas V; Contreres JO
    Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Insulin signal transduction disorder and development of insulin resistance].
    Huang DM; Lu FE
    Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):212-6. PubMed ID: 14628465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential involvement of FRS2 in insulin signaling.
    Delahaye L; Rocchi S; Van Obberghen E
    Endocrinology; 2000 Feb; 141(2):621-8. PubMed ID: 10650943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin receptor--structural and functional characteristics.
    Perz M; Torlińska T
    Med Sci Monit; 2001; 7(1):169-77. PubMed ID: 11208515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3'-kinase.
    Myers MG; Sun XJ; Cheatham B; Jachna BR; Glasheen EM; Backer JM; White MF
    Endocrinology; 1993 Apr; 132(4):1421-30. PubMed ID: 8384986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
    Dokken BB; Sloniger JA; Henriksen EJ
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-3 polyunsaturated fatty acids prevent the defect of insulin receptor signaling in muscle.
    Taouis M; Dagou C; Ster C; Durand G; Pinault M; Delarue J
    Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E664-71. PubMed ID: 11832371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both saturated and n-6 polyunsaturated fat diets reduce phosphorylation of insulin receptor substrate-1 and protein kinase B in muscle during the initial stages of in vivo insulin stimulation.
    Frangioudakis G; Ye JM; Cooney GJ
    Endocrinology; 2005 Dec; 146(12):5596-603. PubMed ID: 16150913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of phosphorylation cascade in insulin action].
    Tobe K; Ueki K; Tamemoto H; Kaburagi Y; Honda R; Kadowaki T
    Nihon Rinsho; 1994 Oct; 52(10):2673-85. PubMed ID: 7983797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental switch from prolonged insulin action to increased insulin sensitivity in protein tyrosine phosphatase 1B-deficient hepatocytes.
    Gonzalez-Rodriguez A; Clampit JE; Escribano O; Benito M; Rondinone CM; Valverde AM
    Endocrinology; 2007 Feb; 148(2):594-608. PubMed ID: 17068137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.